NHS Liverpool Clinical Commissioning Group (CCG) has picked Docobo to expand its service to 4,000 – 5,000 patients a year over the next three years.
NHS Liverpool CCG started scaling up telehealth in 2013, through its More Independent or Mi Programme, which was part-funded by the Innovate UK dallas initiative. The service uses a combination of education, remote monitoring, automated alerting rules, plus access to experienced nurses to support people living with lung conditions, heart failure or diabetes.
It has grown steadily, so that its clinical hub is now supporting around 900 patients at a time, and to date, more than 5,300 patients in total have benefited from it.
With the new Docobo platform, the CCG intends to scale this up to 4,000 – 5,000 patients a year, and use the system to support new clinical pathways and conditions.
Carol Hughes, the clinical and operational lead for health technology at Liverpool Community Health NHS Trust, said:
“Liverpool has been a trailblazer for delivering telehealth at scale and has produced some great improvements in our local patient outcomes and wellbeing. However, this is something that we now want to see used for the benefit of all patients, across the wider local health economy.
It is embedded into the local health economy, and now is the time to grow. This is a really exciting time.”
Evaluation of the Mi Programme showed that it can reduce both emergency admissions and the demand on other health services, as well as making patients feel more confident and in control of their own health.
However, Dave Horsfield, NHS Liverpool CCG’s digital care and innovation lead, also said it had wider ambitions for the service:
“We’ve shown that a high level of professional telehealth support gives reassurance to people and produces good results, but we wanted to stretch the technical capability to open up other options. For example, when people came off the previous programme, we couldn’t offer a step down option that would enable them to use their own smart device to continue to access self-help advice. Because the programme aims to guide people towards longer-term self-management of their conditions, this was one of the gaps we were keen to fill.
“Docobo won the contract because they were best-placed to deliver everything we wanted. We were particularly impressed with the flexibility of their solution and their general attitude towards collaboration.”
Docobo was set up in 2001 and has developed the Doc@Home solution to securely collect, analyse and display patient data.
Patients can be given a small recording device, CarePortal, that was designed with Age UK to be easy to use. With support and training, they can use the CarePortal to enter information into the Doc@Home portal.
Patients who are more comfortable using technology can use their own devices to record information. Clinicians simply use a browser to securely access the information displayed on Doc@Home.
The CCG was keen to implement the Docobo system as soon as possible, to support patients over the winter period, when health services are under severe pressure.
The new system has already gone live, and around 50 patients per week are currently being recruited onto it. This is expected to ramp up as the number of patients using the previous system gradually wind down over the next couple of months.
“Successfully implementing a new system in such a tight time-scale is testimony to the commitment and experience of both Docobo and the cross-organisational telehealth team we have in Liverpool,” said Horsfield.
The CCG has set the maximum potential value of the contract at £11.5 million, if it extends from three to five years, in recognition of the range of patients and pathways that may justify further investment.
Adrian Flowerday, Managing Director, Docobo, said:
“Liverpool is one of the most experienced users of telehealth in the country, by some distance, so we are particularly pleased that they have chosen Docobo to move forward from where they are today.
“Technology has a huge part to play in helping the NHS to cope with rising demand, while delivering a great service for patients. The message is that you need to use technology that delivers results, and that is what Liverpool has chosen to do.”
Adrian Flowerday, Managing Director of Docobo is an NHS Innovation Accelerator (NIA) Fellow, and Docobo’s innovation ArtemusICS, is currently being supported to scale nationally by the NIA.
For more information visit www.docobo.co.uk
